Replies to post #27932 on BioCurex, Inc.(fka BOCX)

[i_invest_utrade]

someone is getting scared...

Contracts take time.
Conversions take time.

So the website said that animals with inflammatory disease have a higher rate of false positives.

The news today says that with the new peptide they have lower the amount of false positives. How is that not important?

We all know there is a baseline RECAF level in humans.

If a physical established this baseline then any increase can be investigated further.

Why is this so hard for you to understand? It's actually pretty simplistic.

[HALF FULL GLASS]

Gold posted, " We have seen a very significant reduction in the amount of false positives in animals with inflammatory diseases." That is all it says Gold...Then you read more into it. Amazing!

Gold stated,"What it does not change is the levels of RECAF that are found in normal individuals."
Great statement Gold but irrelevant thank you. The amount of Recaf changes often in any individual but within limits or cut off values.

OOPS...Gold your statements are worded very cleverly!
Gold stated, "Notice he said "inflammatory". It is a stated fact on the oncopet website that inflammatory conditions will give false positives, such as infection, etc. It would not reduce the main cause of false positives which is normals having varying levels of RECAF who do not have cancer."

Contrary to your carefully worded statement Gold, It will reduce the amount of false positives in the test and as you posted above (Significantly in those with inflammatory diseases! I have witnessed you arguing this in the past regarding Recaf as well as with other markers. You continued to point out that infections were a big issue. Now you want to minimize the fact that Biocurex has Greatly reduced this issue. Very nice work Gold.

Gold, many people have infections and don't even know it. Reducing the amount of infections picked up as false positives does indeed reduce the false positives of the test. This is a great deal for the company!!!